Doç. Dr. Sümeyye KAZANCIOĞLU

1. Managing penicillin resistant pneumococcal meningitis: an international id-iri study

ERDEM H., Dogan E., ANKARALI H., Dragovac G., SEYMAN D., Tarakci A., et al.

European Journal of Clinical Microbiology and Infectious Diseases , cilt.44, sa.11, ss.2855-2866, 2025 (SCI-Expanded, Scopus)

2. Candidemia in critically ill COVID-19 patients: Risk factors and impact on mortality

KAZANCIOĞLU S., BODUR H., MUMCUOĞLU İ., BAŞTUĞ A., Ozbay B. O., Aydos O., et al.

Heliyon , cilt.10, sa.6, 2024 (SCI-Expanded, Scopus)

3. The usefulness of hematological parameters and cerebrospinal fluid indexes in the differential diagnosis of acute bacterial from viral meningitis

KAZANCIOĞLU S., BAŞTUĞ A., Ozbay B. O., Tezcan H., Buyuktarakci C., Akbay A., et al.

Diagnostic Microbiology and Infectious Disease , cilt.107, sa.1, 2023 (SCI-Expanded, Scopus)

4. Prognostic Value of Hemogram-Derived Ratios in Patients with Crimean-Congo Hemorrhagic Fever

KAZANCIOĞLU S., BAŞTUĞ A., Ozdemir B., AKINCI E., BODUR H.

Vector-Borne and Zoonotic Diseases , cilt.22, sa.9, ss.465-471, 2022 (SCI-Expanded, Scopus)

5. Diagnostic value of β-D-glucan alone or combined with Candida score, colonization index and C-reactive protein for candidemia

KAZANCIOĞLU S., BAŞTUĞ A., KAYAASLAN B., MUTLU N. M., Calci E., TURHAN T., et al.

Journal of Infection in Developing Countries , cilt.16, sa.2, ss.362-368, 2022 (SCI-Expanded, Scopus)

6. Are angiotensin converting enzyme (ACE1/ACE2) gene variants associated with the clinical severity of COVID-19 pneumonia? A single-center cohort study

BAŞTUĞ S., Çavdarlı B., BAŞTUĞ A., ŞENCAN İ., Tunçez E., Çakır E. Y., et al.

Anatolian Journal of Cardiology , cilt.26, sa.2, ss.133-140, 2022 (SCI-Expanded, Scopus, TRDizin)

7. Neutralizing antibody response and associated factors in Coronavirus-19 disease (COVID-19) up to one month

BAŞTUĞ A., BODUR H., ŞEKER U. Ö. Ş., KORKULU N., Aydos O., Kehribar E. S., et al.

Turkish Journal of Biochemistry , cilt.47, sa.1, ss.9-18, 2022 (SCI-Expanded, Scopus, TRDizin)

8. Predictive performance of CT for adverse outcomes among COVID-19 suspected patients: A two-center retrospective study

Baysal B., Dogan M. B., Gulbay M., Sorkun M., Koksal M., BAŞTUĞ A., et al.

Bosnian Journal of Basic Medical Sciences , cilt.21, sa.6, ss.738-744, 2021 (SCI-Expanded, Scopus)

9. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19

KAZANCIOĞLU S., Yilmaz F. M., BAŞTUĞ A., Sakalll A., Ozbay B. O., Buyuktarakci C., et al.

Viral Immunology , cilt.34, sa.5, ss.342-351, 2021 (SCI-Expanded, Scopus)

10. Efficacy and cost-effectivity analysis of outpatient parenteral antimicrobial therapy unit in infectious disease clinical practices: Turkey perspective

BAŞTUĞ A., Oksuz E., KAZANCIOĞLU S., Malhan S., Ozbay B. O., BODUR H.

International Journal of Clinical Practice , cilt.75, sa.6, 2021 (SCI-Expanded, Scopus)

11. Evaluation of in Vitro Synergistic Activities of Some Antibiotic Combinations Containing Colistin, Meropenem, Vancomycin, and Minocycline against Oxacillinase-48 Carbapenemase-producing Klebsiella pneumoniae Oksasilinaz-48 Karbapenemaz Üreten Klebsiella pneumoniae Izolatlarina Karşi Kolistin, Meropenem, Vankomisin ve Minosiklin Içeren Bazi Antibiyotik Kombinasyonlarinin in Vitro Sinerjistik Aktivitelerinin Deǧerlendirilmesi

SERTÇELİK A., Baran I., AKINCI E., KAZANCIOĞLU S., BODUR H.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.10, 2021 (ESCI, Scopus)

12. Platelet hyperreactivity related with covid- 19 disease severity

Tuncay M. E., BAŞTUĞ A., Erdogan S., KAZANCIOĞLU S., Yakisik E., ERDEM D., et al.

Ankara Medical Journal , cilt.23, sa.1, ss.386-397, 2021 (Scopus, TRDizin)

13. Analysis of videos about malaria on YouTube: Evaluation of the Turkish and English content Sıtma ile ilgili YouTube videolarının analizi: Türkçe ve İngilizce içeriklerin değerlendirilmesi

KAZANCIOĞLU S., BODUR H.

Turk Hijyen ve Deneysel Biyoloji Dergisi , cilt.78, sa.4, ss.467-476, 2021 (Scopus, TRDizin)

14. Assessment of galectin-1, galectin-3, and prostaglandin e2 levels in patients with covid-19

KAZANCIOĞLU S., Yilmaz F. M., BAŞTUĞ A., Ozbay B. O., Aydos O., Yücel Ç., et al.

Japanese Journal of Infectious Diseases , cilt.74, sa.6, ss.530-536, 2021 (SCI-Expanded, Scopus)

15. The role of haematological parameters in patients with COVID-19 and influenza virus infection

KAZANCIOĞLU S., BAŞTUĞ A., Ozbay B. O., Kemirtlek N., BODUR H.

Epidemiology and Infection , cilt.148, 2020 (SCI-Expanded, Scopus)

16. Clinical and laboratory features of COVID-19: Predictors of severe prognosis

BAŞTUĞ A., BODUR H., Erdogan S., GÖKÇINAR D., KAZANCIOĞLU S., Kosovali B. D., et al.

International Immunopharmacology , cilt.88, 2020 (SCI-Expanded, Scopus)

17. Virolactia in an Asymptomatic Mother with COVID-19

BAŞTUĞ A., Hanifehnezhad A., TAYMAN C., ÖZKUL A., Ozbay O., KAZANCIOĞLU S., et al.

Breastfeeding Medicine , cilt.15, sa.8, ss.488-491, 2020 (SCI-Expanded, Scopus)

18. Crimean-congo hemorrhagic fever: Prognostic factors and the association of leukocyte counts with mortality

BAŞTUĞ A., Kayaaslan B., KAZANCIOĞLU S., Aslaner H., But A., AKINCI E., et al.

Japanese Journal of Infectious Diseases , cilt.69, sa.1, ss.51-55, 2016 (SCI-Expanded, Scopus)

19. Does the course of laboratory parameters help us to predict the outcome of CCHF?

KAZANCIOĞLU S., AKINCI E., BAŞTUĞ A., KAYAASLAN B., But A., Aslaner H., et al.

Turkish Journal of Medical Sciences , cilt.46, sa.2, ss.328-334, 2016 (SCI-Expanded, Scopus, TRDizin)

20. Emergence of multidrug resistant isolates and mortality predictors in patients with solid tumors or hematological malignancies

BAŞTUĞ A., Kayaaslan B., KAZANCIOĞLU S., But A., Aslaner H., AKINCI E., et al.

Journal of Infection in Developing Countries , cilt.9, sa.10, ss.1100-1107, 2015 (SCI-Expanded, Scopus)

Doç. Dr. Sümeyye KAZANCIOĞLU

Yayınlar & Eserler